Clinical Trial Update: Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP

View source ↗

Summary

A clinical trial evaluating 3,4-DAP for Lambert-Eaton Myasthenic Syndrome is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lambert-eaton Myasthenic Syndrome

Drugs mentioned

• 3,4-DAP (3,4-diaminopyridine)

Snippet

Sponsor: Louis H. Weimer, MD | Conditions: Lambert Eaton Myasthenic Syndrome (LEMS) | Status: NO_LONGER_AVAILABLE